A new clinical trial tested low-dose aspirin in patients with colon and rectal cancer, also referred to as colorectal cancer. The researchers wanted to see if taking aspirin daily could help prevent ...
In a new study, low-dose daily aspirin roughly halved the risk of cancer coming back for patients whose tumors had a specific genetic mutation. Daily low-dose aspirin halves the risk of colorectal ...
Aspirin use in patients with PIK3CA-mutated colorectal cancer reduces recurrence risk by over 50%, found a study published in the Journal of Clinical Oncology. The findings could lead to immediate ...
Saga Diagnostics expanded the use of its ultrasensitive blood test to include detection of tiny amounts of colorectal cancer ...
While there are several treatment options for colon cancer, not all of them work for all cancer types. Deficient mismatch repair (dMMR) colon cancer is known to be less responsive to chemotherapy than ...
IRCCS Ospedale Policlinico San Martino with Mayo Clinic and multiple international cancer research centers have delivered a pooled analysis indicating that colon cancer recurrence risk drops below 0.5 ...
A groundbreaking clinical trial has shown that a structured exercise program can significantly reduce the risk of colon cancer returning after surgery and chemotherapy—offering benefits on par with ...
Labcorp added to its suite of tests designed to detect cancer recurrence much earlier than traditional imaging.
A landmark 17-year study has found that a workable exercise plan significantly improves survival and enduring health of people who have experienced colorectal cancer. So much so that, as one of the ...
A large Canadian study found that regular exercise after colon cancer treatment reduces the risk of cancer returning. Patients who followed a structured exercise program had higher survival rates than ...
The preventive immunization Nous-209 works in an initial trial with patients who have 17 times the risk of developing tumors ...
One of the most exciting applications of precision medicine is the minimally to noninvasive technique of isolating tumor DNA from biofluids for diagnostic purposes—the aptly named liquid biopsy. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results